FR2205515B1 - - Google Patents

Info

Publication number
FR2205515B1
FR2205515B1 FR7340568A FR7340568A FR2205515B1 FR 2205515 B1 FR2205515 B1 FR 2205515B1 FR 7340568 A FR7340568 A FR 7340568A FR 7340568 A FR7340568 A FR 7340568A FR 2205515 B1 FR2205515 B1 FR 2205515B1
Authority
FR
France
Prior art keywords
novel compounds
alkoxy
pharmaceutical
convulsant
styryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7340568A
Other languages
English (en)
French (fr)
Other versions
FR2205515A1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11229073A external-priority patent/JPS5246235B2/ja
Priority claimed from JP11229173A external-priority patent/JPS5224032B2/ja
Application filed by Hokuriku Pharmaceutical Co Ltd filed Critical Hokuriku Pharmaceutical Co Ltd
Publication of FR2205515A1 publication Critical patent/FR2205515A1/fr
Application granted granted Critical
Publication of FR2205515B1 publication Critical patent/FR2205515B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
FR7340568A 1972-11-08 1973-11-07 Expired FR2205515B1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP47111219A JPS5210877B2 (de) 1972-11-08 1972-11-08
JP11229073A JPS5246235B2 (de) 1973-10-08 1973-10-08
JP48112289A JPS5224031B2 (de) 1972-11-08 1973-10-08
JP11229173A JPS5224032B2 (de) 1973-10-08 1973-10-08

Publications (2)

Publication Number Publication Date
FR2205515A1 FR2205515A1 (de) 1974-05-31
FR2205515B1 true FR2205515B1 (de) 1978-11-17

Family

ID=27469891

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7340568A Expired FR2205515B1 (de) 1972-11-08 1973-11-07

Country Status (10)

Country Link
JP (2) JPS5210877B2 (de)
AT (1) AT333287B (de)
BE (1) BE807031A (de)
CA (1) CA1055492A (de)
CH (1) CH591465A5 (de)
DE (1) DE2355420A1 (de)
FR (1) FR2205515B1 (de)
GB (1) GB1416412A (de)
NL (1) NL7400278A (de)
SE (1) SE398502B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173380B (hu) * 1977-02-25 1979-04-28 Richter Gedeon Vegyeszet Sposob poluchenija novogo proizvodnogo piridil-piperazina i kislo-additivnykh solejj
JPS53144591A (en) * 1977-05-20 1978-12-15 Asutaabueruke Ag Chem Fuaburii Process for preparing homopirerazine
DE3403778A1 (de) * 1984-02-03 1985-08-08 Degussa Ag, 6000 Frankfurt Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2088018A1 (en) * 1970-05-03 1972-01-07 Rabot Ets David Vasodilatory, substd nicotinic acid amino ester derivs
FR2088019A1 (en) * 1970-05-08 1972-01-07 Rabot Ets David Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
FR2134121A1 (en) * 1971-04-20 1972-12-08 Penciolelli Madeleine Piperazino ethyl phloroglucates prepn - useful as vasodilators

Also Published As

Publication number Publication date
JPS49132088A (de) 1974-12-18
JPS5062983A (de) 1975-05-29
ATA13574A (de) 1976-03-15
NL7400278A (nl) 1975-04-10
SE398502B (sv) 1977-12-27
BE807031A (fr) 1974-03-01
AT333287B (de) 1976-11-10
FR2205515A1 (de) 1974-05-31
DE2355420A1 (de) 1974-07-04
CH591465A5 (de) 1977-09-15
JPS5224031B2 (de) 1977-06-28
JPS5210877B2 (de) 1977-03-26
CA1055492A (en) 1979-05-29
GB1416412A (en) 1975-12-03
SE7400215L (de) 1975-04-16

Similar Documents

Publication Publication Date Title
GB1223690A (en) Substituted chromon-2-carboxylic acids
IE36947B1 (en) New esters their production and their medicinal use
GB1218591A (en) Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation
GB1380225A (en) Biphenylyl- alkanoylaminopyridines and acid addition salts thereof
ES8402309A1 (es) Procedimiento para la preparacion de derivados de penem.
GB1531963A (en) Pyrido(1,2alpha)pyrimidine derivatives
FR2205515B1 (de)
GB1390867A (en) Quinoline derivatives
IE44339L (en) Piperazine derivatives.
GB1260352A (en) New derivatives of benzoxazolin-2-one and methods for producing the same
GB1434805A (en) 5-phenoxy-4-amino pyrimidines
GB1292787A (en) Benzodioxane derivatives and pharmaceutical compositions containing them
GB1361863A (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB1299201A (en) Medicaments derived from thiazolidine carboxylic acid
GB1160064A (en) Indole Derivatives
GB1426200A (en) Nahpthyridine derivatives
GB1266780A (de)
GB1244481A (en) Benzothiazine derivatives and the preparation thereof
GB1327536A (en) Xanthen-2-yl-propionic acids
GB1437149A (en) Spiro-compounds and a process for their preparation
GB1472937A (en) Benzyl alcohol derivatives
GB1259400A (de)
GB1527941A (en) 1-(3-phenylpropyl)-4-(beta-alkoxyacryloyl)piperazine derivatives
GB1188499A (en) Method for the preparation of Basic Derivatives of Xanthone
IE35783L (en) Molecular complexes

Legal Events

Date Code Title Description
ST Notification of lapse